SHANGHAI, March
22, 2012 /PRNewswire-Asia/ -- QIAGEN ( http://www.qiagen.com ) today announced that it has
signed an agreement with Bio-X Centre of Shanghai Jiao Tong University to open
a joint translational medicine lab in Shanghai.
The lab is the first of
its kind between QIAGEN and a major research institution in China and
is a key milestone in the Company's expansion in key emerging markets and as a
leading player in translational medicine.
"Translational
Medicine aims to transform basic research results into clinically applicable
practices. The trend of translational medicine is unstoppable and I think both
scientists and policy makers should adapt this new concept as quick as possible
and work together to improve human health," remarked Professor He Lin,
Director of the Bio-X Center at Shanghai Jiao Tong University and a member of
the Chinese Academy of Sciences.
QIAGEN
will provide the Center with Pyromark Q24MDx and QIAcube instruments and
related products. The Pyromark system is a state-of-the-art pyrosequencing
instrument which allows researchers to, among many things, study gene mutations
that play a role in various diseases. By studying biomarkers and pathways,
researchers can turn viable disease related biomarkers into clinically
applicable molecular diagnostic assays. Bio-X Center will use the instruments
and QIAGEN reagents in a variety of research fields including biomarker
validation and analysis.
"Translational
medicine is quickly becoming the future of medicine by applying basic research
to develop clinical diagnostics and therapies that prevent disease and optimize
patient care," said Dr. Victor Shi, Asia Pacific President of QIAGEN.
"Through this agreement with the Bio-X Center we can leverage our leading
positions as a solutions provider in biological research, drug discovery and
personalized healthcare to help develop better diagnostics and therapies for
the Chinese people."
QIAGEN
technologies are a staple in sample preparation and are playing an important
role in driving the development of the drug discovery and personalized
healthcare markets. QIAGEN offers proprietary systems for the automation of
entire workflows in all application areas and customer segments. Through
greater standardization, higher accuracy and reproducibility of results and
increased efficiency, QIAGEN platforms are helping to drive the dissemination
of molecular testing technologies in healthcare around the world.
About QIAGEN
QIAGEN
N.V., a Netherlands holding company, is the leading global provider of sample
and assay technologies. Sample technologies are used to isolate and process DNA,
RNA and proteins from biological samples such as blood or tissue. Assay
technologies are used to make such isolated bio-molecules visible. QIAGEN has
developed and markets more than 500 sample and assay products as well as
automated solutions for such consumables.
The
company provides its products to molecular diagnostics laboratories, academic
researchers, pharmaceutical and biotechnology companies, and applied testing
customers for purposes such as forensics, animal or food testing and
pharmaceutical process control.
QIAGEN's
assay technologies include one of the broadest panels of molecular diagnostic
tests available worldwide. This panel includes the digene HPV Test, which is
regarded as a "gold standard" in testing for high-risk types of human
papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad
suite of solutions for infectious disease testing and companion diagnostics. As
of December 31, 2011, QIAGEN employed nearly 3,900 people in over 35 locations
worldwide.
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Strategy, Investment and Management, focusing Healthcare and Life Science with expertise in ASEAN. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programmes. Many thanks for visiting www.yourvietnamexpert.com and/or contacting us at contact@yourvietnamexpert.com
No comments:
Post a Comment